University Of California, Berkeley

This study tests a varenicline nasal spray for treating dry eye and meibomian gland dysfunction. Researchers will measure changes in tear film thickness and stability in 65 adults with mild to moderate symptoms. The goal is to see if the spray improves eye comfort and gland funct…

This study tests whether a 12-week high-intensity exercise program can improve language, thinking, and physical health in 120 adults with aphasia (trouble speaking or understanding language) after a stroke. Participants are randomly assigned to either high-intensity or low-intens…

This study looks at whether eating only during certain hours of the day (time-restricted eating) can help people with bipolar disorder feel better. About 150 adults who are already on medication for bipolar disorder will track their eating, sleep, and mood for 2 weeks, then follo…

This study tests whether a special memory support program can help people aged 50 and older remember and stick to their sleep treatment. The program uses simple memory strategies alongside standard sleep therapy. Researchers will track sleep quality, daily functioning, and life s…

This study is testing a digital cognitive behavioral therapy program (SilverCloud) in Spanish, with added support from a peer coach, for Latino adults in San Francisco with depression or anxiety. 213 participants will either use the program on their own or with weekly check-ins f…

This study tests whether installing cooling equipment in low-income homes in Bangladesh can reduce heat stress and improve health. About 1,500 participants will have sensors placed inside and outside their homes and wear monitors to track heart rate, sleep, and other health measu…

This study looks at how seeing one skin image after another can influence a doctor's judgment, potentially causing errors. Researchers will test over 10,000 people, including doctors and untrained volunteers, to measure these biases. The goal is to find ways to reduce mistakes in…

This study aims to understand how psilocybin, the active ingredient in magic mushrooms, alters visual perception and brain activity. Researchers will use fMRI brain scans to measure responses to visual stimuli in 80 healthy adults after taking different doses of psilocybin. The g…

This early-stage study is looking at how a single dose of psilocybin, the active ingredient in magic mushrooms, might affect brain structure and function in healthy older adults aged 60 to 85. Researchers will use MRI scans to measure changes in brain plasticity and activity. The…